Bonfils S, Bernier J J, Mignon M, Hautefeuille P, Corbic M, Marteau J
Nouv Presse Med. 1975 Oct 11;4(33):2377-81.
Metiamide an histamine H2-receptors antagonist has been used to treat a case of Zollinger-Ellison syndrome characterized by a long standing diarrhea, an important gastric hypersecretion and a moderatly elevated plasma gastrin but without digestive ulceration. At the dose of 600 mg per day, Metiamide induced a complete suppression of acid secretion, an effect which lasted for 15 days after stopping the drug. Accordingly and since the only finding at time of laparotomy was a small lymph node enlarged with endocrine metastatic tissue, the stomach was left intact and Metiamide pursued. During the first 4 months of chronic administration of Metiamide, acid secretion was maintained at levels below 25 p.cent of initial values. Ulteriorly however, although dosages of Metiamide were increased, acid hypersecretion resumed and a duodenal ulcer developed. Total gastrectomy was then performed 11 months after the beginning of Metiamide. In spite of the failure of Metiamide treatment, the long term follow up of this case of Zollinger-Ellison Syndrome, allowed us to get theoretical and practical informations.
甲硫米特是一种组胺H2受体拮抗剂,曾用于治疗一例佐林格-埃利森综合征患者,该患者长期腹泻、胃酸分泌过多且血浆胃泌素中度升高,但无消化性溃疡。每天服用600毫克甲硫米特可使胃酸分泌完全受到抑制,停药后这种作用持续了15天。因此,由于剖腹探查时唯一的发现是一个伴有内分泌转移组织的小淋巴结肿大,胃未受影响,继续使用甲硫米特。在长期服用甲硫米特的前4个月,胃酸分泌维持在初始值的25%以下。然而,后来尽管增加了甲硫米特的剂量,胃酸分泌过多又复发,并且出现了十二指肠溃疡。在开始使用甲硫米特11个月后进行了全胃切除术。尽管甲硫米特治疗失败,但对该例佐林格-埃利森综合征患者的长期随访使我们获得了理论和实践信息。